The program is still filling in: some talks have no title yet and more speakers will be added. We’ll add new sessions, the organizations presenting them and stand numbers once the floor plan is published.

Merck at Festival of Biologics USA 2027

Apr 13–14, 2027 Boston, MA ~2k attendees Website

Merck takes part in 2 sessions at Festival of Biologics USA 2027 in Boston. Its sessions span how antibodies are designed and how they are made. They cover de novo design of recombinant antibodies and advances in continuous downstream processing.

OrganizationFestival of Biologics USA 2027 Attendance
Merck
Rahway, NJ
merck.com
Large pharma
Develops and markets medicines and vaccines, including the cancer immunotherapy Keytruda; known as MSD outside the US and Canada.
Talk
Tue Apr 13
12:00
Continuous downstream processing advances
Bioprocessing
Talk
Wed Apr 14
14:40
De novo designs for recombinant antibodies
Protein Engineering
Also
Presenting at the meeting, beyond the sessions above

Explore the full Festival of Biologics USA 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics USA 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Merck

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Festival of Biologics or its organizers. Submit a correction